Yordam MedasPro up to 27 cross site scripting

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
5.1$0-$5k0.00

Summaryinfo

A vulnerability categorized as problematic has been discovered in Yordam MedasPro up to 27. This affects an unknown function. Such manipulation leads to cross site scripting. This vulnerability is documented as CVE-2023-4676. The attack can be executed remotely. There is not any exploit available. It is advisable to upgrade the affected component.

Detailsinfo

A vulnerability was found in Yordam MedasPro up to 27. It has been rated as problematic. Affected by this issue is an unknown functionality. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. CVE summarizes:

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Yordam MedasPro allows Reflected XSS. This issue affects MedasPro: before 28.

The weakness was released 09/15/2023. The advisory is available at usom.gov.tr. This vulnerability is handled as CVE-2023-4676 since 08/31/2023. Successful exploitation requires user interaction by the victim. The technical details are unknown and an exploit is not available. This vulnerability is assigned to T1059.007 by the MITRE ATT&CK project.

Upgrading to version 28 eliminates this vulnerability.

If you want to get best quality of vulnerability data, you may have to visit VulDB.

Productinfo

Vendor

Name

Version

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 5.2
VulDB Meta Temp Score: 5.1

VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍

CNA Base Score: 6.1
CNA Vector: 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: Cross site scripting
CWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Yes

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: Upgrade
Status: 🔍

0-Day Time: 🔍

Upgrade: MedasPro 28

Timelineinfo

08/31/2023 🔍
09/15/2023 +15 days 🔍
09/15/2023 +0 days 🔍
05/21/2026 +979 days 🔍

Sourcesinfo

Advisory: usom.gov.tr
Status: Confirmed

CVE: CVE-2023-4676 (🔍)
GCVE (CVE): GCVE-0-2023-4676
GCVE (VulDB): GCVE-100-239786

Entryinfo

Created: 09/15/2023 08:04
Updated: 05/21/2026 13:23
Changes: 09/15/2023 08:04 (48), 05/21/2026 13:23 (17)
Complete: 🔍
Cache ID: 216::103

If you want to get best quality of vulnerability data, you may have to visit VulDB.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Do you need the next level of professionalism?

Upgrade your account now!